The usefulness of evaluative outcome measures in patients with multiple sclerosis

被引:51
作者
de Groot, V.
Beckerman, H.
Uitdehaag, B. M. J.
de Vet, H. C. W.
Lankhorst, G. J.
Polman, C. H.
Bouter, L. M.
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, NL-1007 MB Amsterdam, Netherlands
关键词
multiple sclerosis; evaluative outcome measures; responsiveness; minimally important change; smallest real change;
D O I
10.1093/brain/awl223
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To select the most useful evaluative outcome measures for early multiple sclerosis, we included 156 recently diagnosed patients in a 3-year follow-up study, and assessed them on 23 outcome measures in the domains of disease-specific outcomes, physical functioning, mental health, social functioning and general health. A global rating scale (GRS) and the Expanded Disability Status Scale (EDSS) were used as external criteria to determine the minimally important change (MIC) for each outcome measure. Subsequently, we determined whether the outcome measures could detect their MIC reliably. From these, per domain the outcome measure that was found to be most sensitive to changes (responsive) was identified. At group level, 11 outcomes of the domains of physical functioning, mental health, social functioning and general health could reliably detect the MIC. Of these 11, the most responsive measures per domain were the Medical Outcome Study 36 Short Form sub-scale physical functioning (SF36pf), the Disability and Impact Profile (DIP) sub-scale psychological, the Rehabilitation Activities Profile sub-scale occupation (RAPocc) and the SF36 sub-scale health, respectively. Overall, the most responsive measures were the SF36pf and the RAPocc. In individual patients, none of the measures could reliably detect the MIC. In sum, in the early stages of multiple sclerosis the most useful evaluative outcome measures for research are the SF36pf (physical functioning) and the RAPocc (social functioning).
引用
收藏
页码:2648 / 2659
页数:12
相关论文
共 79 条
[1]   Rasch analysis of the Rivermead Mobility Index: A study using mobility measures of first-stroke inpatients [J].
Antonucci, G ;
Aprile, T ;
Paolucci, S .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2002, 83 (10) :1442-1449
[2]   Smallest real difference, a link between reproducibility and responsiveness [J].
Beckerman, H ;
Roebroeck, ME ;
Lankhorst, GJ ;
Becher, JG ;
Bezemer, PD ;
Verbeek, ALM .
QUALITY OF LIFE RESEARCH, 2001, 10 (07) :571-578
[3]   Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome [J].
Bessette, L ;
Sangha, O ;
Kuntz, KM ;
Keller, RB ;
Lew, RA ;
Fossel, AH ;
Katz, JN .
MEDICAL CARE, 1998, 36 (04) :491-502
[4]   Responsiveness of functional status in low back pain: A comparison of different instruments [J].
Beurskens, AJHM ;
deVet, HCW ;
Koke, AJA .
PAIN, 1996, 65 (01) :71-76
[5]   Measurement of health related quality of life in multiple sclerosis patients [J].
Brunet, DG ;
Hopman, WM ;
Singer, MA ;
Edgar, CM ;
MacKenzie, TA .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1996, 23 (02) :99-103
[6]   Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales [J].
Cella, D ;
Eton, DT ;
Lai, JS ;
Peterman, AH ;
Merkel, DE .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 24 (06) :547-561
[7]   Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening [J].
Cella, D ;
Hahn, EA ;
Dineen, K .
QUALITY OF LIFE RESEARCH, 2002, 11 (03) :207-221
[8]   Intrarater and interrater reliability of the MS functional composite outcome measure [J].
Cohen, JA ;
Fischer, JS ;
Bolibrush, DM ;
Jak, AJ ;
Kniker, JE ;
Mertz, LA ;
Skaramagas, TT ;
Cutter, GR .
NEUROLOGY, 2000, 54 (04) :802-806
[9]   Use of the Multiple Sclerosis Functional Composite as an outcome measure in a phase 3 clinical trial [J].
Cohen, JA ;
Cutter, GR ;
Fischer, JS ;
Goodman, AD ;
Heidenreich, FR ;
Jak, AJ ;
Kniker, JE ;
Kooijmans, MF ;
Lull, JM ;
Sandrock, AW ;
Simon, JH ;
Simonian, NA ;
Whitaker, JN .
ARCHIVES OF NEUROLOGY, 2001, 58 (06) :961-967
[10]   Factor structure of the Disability and Impact Profile in patients with multiple sclerosis [J].
Cohen, L ;
Pouwer, F ;
Pfennings, LEMA ;
Lankhorst, GJ ;
van der Ploeg, HM ;
Polman, CH ;
Adèr, HJ ;
Jonnson, A ;
Vleugels, L .
QUALITY OF LIFE RESEARCH, 1999, 8 (1-2) :141-150